Skip to main content

Peer Review reports

From: Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells

Original Submission
13 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
13 Jun 2022 Reviewed Reviewer Report
1 Jul 2022 Reviewed Reviewer Report
31 Aug 2022 Author responded Author comments - Lihong Liu
Resubmission - Version 4
31 Aug 2022 Submitted Manuscript version 4
4 Sep 2022 Author responded Author comments - Lihong Liu
Resubmission - Version 5
4 Sep 2022 Submitted Manuscript version 5
9 Sep 2022 Author responded Author comments - Lihong Liu
Resubmission - Version 6
9 Sep 2022 Submitted Manuscript version 6
25 Sep 2022 Reviewed Reviewer Report
4 Oct 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
6 Oct 2022 Editorially accepted
27 Oct 2022 Article published 10.1186/s12885-022-10158-6

You can find further information about peer review here.

Back to article page